Grants and Contributions:
Title:
Development of a Novel Testing System, MetProfiling, for Precision Medicine and Health Monitoring - Stage 2
Agreement Number:
1033937
Agreement Value:
$148,000.00
Agreement Date:
Aug 30, 2025 - Mar 29, 2026
Description:
This project aims to advance the Firm's metabolomics profiling system into a scalable, high-throughput platform for clinical and precision health applications. Building on foundational work completed in the first year, the focus now shifts to upgrading lab methods and bioinformatics tools to support the processing of over 300 samples per day, validating the system with large-scale cohorts (~30,000 samples), and developing a prototype precision health platform that integrates analytics, a database, and AI-driven health assessment tools. The outcome will be a fully validated and operational system ready for commercial use in population-scale diagnostics and health monitoring.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Edmonton, Alberta, CA T6N 1H1
Reference Number:
172-2025-2026-Q2-1033937
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
704841329
Recipient Type:
For-profit organization
Recipient's Legal Name:
Nova Medical Testing Inc.
Federal Riding Name:
Edmonton Mill Woods
Federal Riding Number:
48017
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710